Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Homoharringtonine

EU orphan designation number: EU/3/04/228   
Active ingredient: Homoharringtonine
Indication: Treatment of acute myeloid leukaemia
Sponsor: Teva Pharma GmbH
Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2004 Orphan designation EMEA/OD/051/04 (2004)4190 of 20/10/2004
25/11/2008 Change of name and/or address of sponsor
08/01/2009 Transfer of orphan designation EMEA/OD/051/04/T/01 (2009)18 of 05/01/2009
13/12/2012 Transfer of orphan designation EMEA/OD/051/04/T/02 (2012)9406 of 06/12/2012
27/04/2016 Removal of orphan designation from Community Register